Redundancy in the World of MAP Kinases: All for One
Open accessThe DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.
Abstract
The protein kinases ERK1 and ERK2 are the effector components of the prototypical ERK1/2 mitogen-activated protein (MAP) kinase pathway. This signaling pathway regulates cell proliferation, differentiation and survival, and is essential for embryonic development and cellular homeostasis. ERK1 and ERK2 homologs share similar biochemical properties but whether they exert specific physiological functions or act redundantly has been a matter of controversy. However, recent studies now provide compelling evidence in support of functionally redundant roles of ERK1 and ERK2 in embryonic development and physiology. In this review, we present a critical assessment of the evidence for the functional specificity or redundancy of MAP kinase isoforms. We focus on the ERK1/ERK2 pathway but also discuss the case of JNK and p38 isoforms.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Global quantification of mammalian gene expression control
Schwanhäusser, B., Busse, D., Li, N., Dittmar, G., Schuchhardt, J., Wolf, J., Chen, W., & Selbach, M. (2011) · Nature · doi:10.1038/nature10098 · Cited by 6,566
Requirement of JNK for Stress- Induced Activation of the Cytochrome c-Mediated Death Pathway
Tournier, C., Hess, P., Yang, D. D., Xu, J., Turner, T. K., Nimnual, A., Bar-Sagi, D., Jones, S. N., Flavell, R. A., & Davis, R. J. (2000) · Science · doi:10.1126/science.288.5467.870 · Cited by 1,728
Defective Thymocyte Maturation in p44 MAP Kinase (Erk 1) Knockout Mice
Pagès, G., Guérin, S., Grall, D., Bonino, F., Smith, A., Anjuere, F., Auberger, P., & Pouysségur, J. (1999) · Science · doi:10.1126/science.286.5443.1374 · Cited by 654
Mazzucchelli, C., Vantaggiato, C., Ciamei, A., Fasano, S., Pakhotin, P., Krezel, W., Welzl, H., Wolfer, D. P., Pagès, G., Valverde, O., et al. (2002) · Neuron · doi:10.1016/s0896-6273(02)00716-x · Cited by 456 · cited 1×
“Contradictory findings have also been reported about the specific role of ERK1 in emotional Frontiers in Cell and Developmental Biology | www.frontiersin.org 2 June 2016 | Volume 4 | Article 67 learning and memory (Selcher et al., 2001; Mazzucchelli et al., 2002).”
BackgroundAn essential function of the mitogen‐activated protein kinase Erk2 in mouse trophoblast development
Saba‐El‐Leil, M. K., Vella, F. D. J., Vernay, B., Voisin, L., Chen, L., Labrecque, N., Ang, S., & Meloche, S. (2003) · The EMBO Reports · doi:10.1038/sj.embor.embor939 · Cited by 366 · cited 2×
“In contrast, invalidation of the Erk2 gene in mouse severely compromises the formation of ectoplacental cone and extra-embryonic ectoderm, which give rise to mature trophoblast derivatives in the fetus (Saba-El-Leil et al., 2003).”
BackgroundInfluentialSelf-citationExtracellular signal-regulated kinase 2 is necessary for mesoderm differentiation
Yao, Y., Li, W., Wu, J., Germann, U. A., Su, M. S. S., Kuida, K., & Boucher, D. M. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2134254100 · Cited by 323 · cited 1×
“Therefore, Erk2 disruption leads to embryonic lethality early in mouse development after the implantation stage at embryonic day (E) 6.5 (Hatano et al., 2003; Saba-El-Leil et al., 2003; Yao et al., 2003).”
BackgroundInfluentialEssential role for ERK2 mitogen‐activated protein kinase in placental development
Hatano, N., Mori, Y., Oh‐hora, M., Kosugi, A., Fujikawa, T., Nakai, N., Niwa, H., Miyazaki, J., Hamaoka, T., & Ogata, M. (2003) · Genes to Cells · doi:10.1046/j.1365-2443.2003.00680.x · Cited by 296
Newbern, J., Zhong, J., Wickramasinghe, R. S., Li, X., Wu, Y., Samuels, I., Cherosky, N., Karlo, J. C., O'Loughlin, B., Wikenheiser, J., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0805239105 · Cited by 172 · cited 1×
“Conditional inactivation of Erk2 in the developing neural crest leads to craniofacial abnormalities and conotruncal cardiac defects, which are exacerbated by the additional deletion of Erk1 (Newbern et al., 2008).”
BackgroundERK2 Contributes to the Control of Social Behaviors in Mice
Satoh, Y., Endo, S., Nakata, T., Kobayashi, Y., Yamada, K., Ikeda, T., Takeuchi, A., Hiramoto, T., Watanabe, Y., & Kazama, T. (2011) · The Journal of Neuroscience · doi:10.1523/jneurosci.2349-11.2011 · Cited by 145
ERK2 is required for efficient terminal differentiation of skeletal myoblasts
Li, J., & Johnson, S. E. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.05.051 · Cited by 137 · cited 1×
“On the other hand, depletion of ERK2 was reported to specifically impair terminal differentiation of skeletal myoblasts (Li and Johnson, 2006), replication of hepatocytes (Fremin et al., 2007; Bessard et al., 2008), transforming growth factor-beta-induced collagen synthesis (Li et al., 2009),…”
Background
Research works printed but not linked: 103
- Aceves-Luquero, 2009, ERK2, but not ERK1, mediates acquired and “de novo” resistance to imatinib mesylate: implication for CML therapy, PLoS ONE, 4, e6124, 10.1371/journal.pone.0006124 · DOI
- Adams, 2000, Essential role of p38alpha MAP kinase in placental but not embryonic cardiovascular development, Mol. Cell, 6, 109, 10.1016/S1097-2765(05)00014-6 · DOI · Paper page
- Aebersold, 2004, Extracellular signal-regulated kinase 1c (ERK1c), a novel 42-kilodalton ERK, demonstrates unique modes of regulation, localization, and function, Mol. Cell. Biol., 24, 10000, 10.1128/MCB.24.22.10000-10015.2004 · DOI
- Allen, 2000, Deficiency of the stress kinase p38alpha results in embryonic lethality: characterization of the kinase dependence of stress responses of enzyme-deficient embryonic stem cells, J. Exp. Med., 191, 859, 10.1084/jem.191.5.859 · DOI · Paper page
- Aoidi, 2016, Functional redundancy of the kinases MEK1 and MEK2: rescue of the Mek1 mutant phenotype by Mek2 knock-in reveals a protein threshold effect, Sci. Signal., 9, ra9, 10.1126/scisignal.aad5658 · DOI
- Beardmore, 2005, Generation and characterization of p38beta (MAPK11) gene-targeted mice, Mol. Cell. Biol., 25, 10454, 10.1128/MCB.25.23.10454-10464.2005 · DOI · Paper page
- Bessard, 2008, RNAi-mediated ERK2 knockdown inhibits growth of tumor cells in vitro and in vivo, Oncogene, 27, 5315, 10.1038/onc.2008.163 · DOI
- Bishop, 1999, Acquisition of inhibitor-sensitive protein kinases through protein design, Pharmacol. Ther., 82, 337, 10.1016/S0163-7258(98)00060-6 · DOI
- Bonito, 2014, Control of gp130 expression by the mitogen-activated protein kinase ERK2, Oncogene, 33, 2255, 10.1038/onc.2013.159 · DOI
- Bost, 2005, The extracellular signal-regulated kinase isoform ERK1 is specifically required for in vitro and in vivo adipogenesis, Diabetes, 54, 402, 10.2337/diabetes.54.2.402 · DOI · Paper page
- Boulton, 1991, Identification of multiple extracellular signal-regulated kinases (ERKs) with antipeptide antibodies, Cell Regul., 2, 357, 10.1091/mbc.2.5.357 · DOI · Paper page
- Boulton, 1991, ERKs: a family of protein-serine/threonine kinases that are activated and tyrosine phosphorylated in response to insulin and NGF, Cell, 65, 663, 10.1016/0092-8674(91)90098-J · DOI · Paper page
- Boulton, 1990, An insulin-stimulated protein kinase similar to yeast kinases involved in cell cycle control, Science, 249, 64, 10.1126/science.2164259 · DOI · Paper page
- Bourcier, 2006, p44 mitogen-activated protein kinase (extracellular signal-regulated kinase 1)-dependent signaling contributes to epithelial skin carcinogenesis, Cancer Res., 66, 2700, 10.1158/0008-5472.CAN-05-3129 · DOI · Paper page
- Busca, 2015, ERK1 and ERK2 present functional redundancy in tetrapods despite higher evolution rate of ERK1, BMC Evol. Biol., 15, 179, 10.1186/s12862-015-0450-x · DOI
- Chan, 2013, Erk1 and Erk2 are required for maintenance of hematopoietic stem cells and adult hematopoiesis, Blood, 121, 3594, 10.1182/blood-2012-12-476200 · DOI
- Chuang, 1994, Functional divergence of the MAP kinase pathway. ERK1 and ERK2 activate specific transcription factors, FEBS Lett., 346, 229, 10.1016/0014-5793(94)00480-3 · DOI · Paper page
- Courcelles, 2013, Phosphoproteome dynamics reveal novel ERK1/2 MAP kinase substrates with broad spectrum of functions, Mol. Syst. Biol., 9, 669, 10.1038/msb.2013.25 · DOI · Paper page
- Criado, 2014, Alternative p38 MAPKs are essential for collagen-induced arthritis, Arthritis Rheumatol., 66, 1208, 10.1002/art.38327 · DOI
- Cuadrado, 2010, Mechanisms and functions of p38 MAPK signalling, Biochem. J., 429, 403, 10.1042/BJ20100323 · DOI · Paper page
- Cuenda, 2007, p38 MAP-kinases pathway regulation, function and role in human diseases, Biochim. Biophys. Acta, 1773, 1358, 10.1016/j.bbamcr.2007.03.010 · DOI · Paper page
- Davis, 2000, Signal transduction by the JNK group of MAP kinases, Cell, 103, 239, 10.1016/S0092-8674(00)00116-1 · DOI · Paper page
- del Barco Barrantes, 2011, Genetic analysis of specific and redundant roles for p38alpha and p38beta MAPKs during mouse development, Proc. Natl. Acad. Sci. U.S.A., 108, 12764, 10.1073/pnas.1015013108 · DOI
- Del Reino, 2014, Pro-oncogenic role of alternative p38 mitogen-activated protein kinases p38gamma and p38delta, linking inflammation and cancer in colitis-associated colon cancer, Cancer Res., 74, 6150, 10.1158/0008-5472.CAN-14-0870 · DOI
- Di Benedetto, 2007, Differential mRNA distribution of components of the ERK/MAPK signalling cascade in the adult mouse brain, J. Comp. Neurol., 500, 542, 10.1002/cne.21186 · DOI
- D'Souza, 2008, The Erk2 MAPK regulates CD8 T cell proliferation and survival, J. Immunol., 181, 7617, 10.4049/jimmunol.181.11.7617 · DOI · Paper page
- Dudley, 1995, A synthetic inhibitor of the mitogen-activated protein kinase cascade, Proc. Natl. Acad. Sci. U.S.A., 92, 7686, 10.1073/pnas.92.17.7686 · DOI · Paper page
- Dumesic, 2009, Erk1/2 MAP kinases are required for epidermal G2/M progression, J. Cell Biol., 185, 409, 10.1083/jcb.200804038 · DOI
- English, 1996, Activation of p42 mitogen-activated protein kinase in hippocampal long term potentiation, J. Biol. Chem., 271, 24329, 10.1074/jbc.271.40.24329 · DOI · Paper page
- Escós, 2016, p38gamma and p38delta mitogen activated protein kinases (MAPKs), new stars in the MAPK galaxy, Front. Cell Dev. Biol., 4, 10.3389/fcell.2016.00031 · DOI · Paper page
- Favata, 1998, Identification of a novel inhibitor of mitogen-activated protein kinase kinase, J. Biol. Chem., 273, 18623, 10.1074/jbc.273.29.18623 · DOI · Paper page
- Fischer, 2005, The role of erk1 and erk2 in multiple stages of T cell development, Immunity, 23, 431, 10.1016/j.immuni.2005.08.013 · DOI · Paper page
- Fremin, 2007, ERK2 but not ERK1 plays a key role in hepatocyte replication: an RNAi-mediated ERK2 knockdown approach in wild-type and ERK1 null hepatocytes, Hepatology, 45, 1035, 10.1002/hep.21551 · DOI · Paper page
- Fremin, 2010, From basic research to clinical development of MEK1/2 inhibitors for cancer therapy, J. Hematol. Oncol., 3, 8, 10.1186/1756-8722-3-8 · DOI · Paper page
- Fremin, 2015, Functional redundancy of ERK1 and ERK2 MAP Kinases during development, Cell Rep., 12, 913, 10.1016/j.celrep.2015.07.011 · DOI · Paper page
- Furlan, 2012, Met acts through Abl to regulate p53 transcriptional outcomes and cell survival in the developing liver, J. Hepatol., 57, 1292, 10.1016/j.jhep.2012.07.044 · DOI
- Fyffe-Maricich, 2011, The ERK2 mitogen-activated protein kinase regulates the timing of oligodendrocyte differentiation, J. Neurosci., 31, 843, 10.1523/JNEUROSCI.3239-10.2011 · DOI · Paper page
- Gonzalez, 1991, Identification of substrate recognition determinants for human ERK1 and ERK2 protein kinases, J. Biol. Chem., 266, 22159, 10.1016/S0021-9258(18)54548-8 · DOI · Paper page
- Gonzalez-Teran, 2013, Eukaryotic elongation factor 2 controls TNF-alpha translation in LPS-induced hepatitis, J. Clin. Invest., 123, 164, 10.1172/JCI65124 · DOI · Paper page
- Gonzalez-Teran, 2016, p38gamma and delta promote heart hypertrophy by targeting the mTOR-inhibitory protein DEPTOR for degradation, Nat. Commun., 7, 10477, 10.1038/ncomms10477 · DOI
- Grueter, 2006, Extracellular-signal regulated kinase 1-dependent metabotropic glutamate receptor 5-induced long-term depression in the bed nucleus of the stria terminalis is disrupted by cocaine administration, J. Neurosci., 26, 3210, 10.1523/JNEUROSCI.0170-06.2006 · DOI · Paper page
- Guihard, 2010, The MAPK ERK1 is a negative regulator of the adult steady-state splenic erythropoiesis, Blood, 115, 3686, 10.1182/blood-2009-09-242487 · DOI
- Hanlon, 2001, ERK2- and p90(Rsk2)-dependent pathways regulate the CCAAT/enhancer-binding protein-beta interaction with serum response factor, J. Biol. Chem., 276, 38449, 10.1074/jbc.M102165200 · DOI
- He, 2011, Erk1 positively regulates osteoclast differentiation and bone resorptive activity, PLoS ONE, 6, e24780, 10.1371/journal.pone.0024780 · DOI · Paper page
- Heffron, 2009, Brain-specific deletion of extracellular signal-regulated kinase 2 mitogen-activated protein kinase leads to aberrant cortical collagen deposition, Am. J. Pathol., 175, 2586, 10.2353/ajpath.2009.090130 · DOI
- Hui, 2007, p38alpha suppresses normal and cancer cell proliferation by antagonizing the JNK-c-Jun pathway, Nat. Genet., 39, 741, 10.1038/ng2033 · DOI · Paper page
- Hwang, 2009, Extracellular signal-regulated kinase 2-dependent phosphorylation induces cytoplasmic localization and degradation of p21Cip1, Mol. Cell. Biol., 29, 3379, 10.1128/MCB.01758-08 · DOI
- Jaeschke, 2006, JNK2 is a positive regulator of the cJun transcription factor, Mol. Cell, 23, 899, 10.1016/j.molcel.2006.07.028 · DOI · Paper page
- Kashiwada, 1996, Activation of mitogen-activated protein kinases via CD40 is distinct from that stimulated by surface IgM on B cells, Eur. J. Immunol., 26, 1451, 10.1002/eji.1830260708 · DOI
- Kultz, 1998, Phylogenetic and functional classification of mitogen- and stress-activated protein kinases, J. Mol. Evol., 46, 571, 10.1007/PL00006338 · DOI · Paper page
- Lefloch, 2008, Single and combined silencing of ERK1 and ERK2 reveals their positive contribution to growth signaling depending on their expression levels, Mol. Cell. Biol., 28, 511, 10.1128/MCB.00800-07 · DOI · Paper page
- Lewis, 1998, Signal transduction through MAP kinase cascades, Adv. Cancer Res., 74, 49, 10.1016/S0065-230X(08)60765-4 · DOI · Paper page
- Li, 2009, Efficient inhibition of fibroblast proliferation and collagen expression by ERK2 siRNAs, Biochem. Biophys. Res. Commun., 382, 259, 10.1016/j.bbrc.2009.02.165 · DOI
- Li, 1994, Genomic loci of human mitogen-activated protein kinases, Oncogene, 9, 647
- Li, 2011, Evolutionary history of the vertebrate mitogen activated protein kinases family, PLoS ONE, 6, e26999, 10.1371/journal.pone.0026999 · DOI
- Lips, 2004, MEK1-ERK2 signaling pathway protects myocardium from ischemic injury in vivo, Circulation, 109, 1938, 10.1161/01.CIR.0000127126.73759.23 · DOI · Paper page
- Liu, 2004, The MAP kinase pathway is required for entry into mitosis and cell survival, Oncogene, 23, 763, 10.1038/sj.onc.1207188 · DOI
- Marchi, 2008, The N-terminal domain of ERK1 accounts for the functional differences with ERK2, PLoS ONE, 3, e3873, 10.1371/journal.pone.0003873 · DOI · Paper page
- Marchi, 2010, ERK1 nucleocytoplasmic shuttling rate depends on specific N-terminal aminoacids, Biochem. Biophys. Res. Commun., 398, 166, 10.1016/j.bbrc.2010.06.044 · DOI
- Matos, 2005, DNFB activates MAPKs and upregulates CD40 in skin-derived dendritic cells, J. Dermatol. Sci., 39, 113, 10.1016/j.jdermsci.2005.03.011 · DOI
- Meloche, 1995, Cell cycle reentry of mammalian fibroblasts is accompanied by the sustained activation of p44mapk and p42mapk isoforms in the G1 phase and their inactivation at the G1/S transition, J. Cell. Physiol., 163, 577, 10.1002/jcp.1041630319 · DOI
- Meloche, 2012, Mitogen-activated protein kinases, 1082, 10.1007/978-1-4419-0461-4_193 · DOI
- Mudgett, 2000, Essential role for p38alpha mitogen-activated protein kinase in placental angiogenesis, Proc. Natl. Acad. Sci. U.S.A., 97, 10454, 10.1073/pnas.180316397 · DOI · Paper page
- Nekrasova, 2005, ERK1-deficient mice show normal T cell effector function and are highly susceptible to experimental autoimmune encephalomyelitis, J. Immunol., 175, 2374, 10.4049/jimmunol.175.4.2374 · DOI · Paper page
- Pages, 1993, Mitogen-activated protein kinases p42mapk and p44mapk are required for fibroblast proliferation, Proc. Natl. Acad. Sci. U.S.A., 90, 8319, 10.1073/pnas.90.18.8319 · DOI · Paper page
- Papkoff, 1994, p42 mitogen-activated protein kinase and p90 ribosomal S6 kinase are selectively phosphorylated and activated during thrombin-induced platelet activation and aggregation, Mol. Cell. Biol., 14, 463, 10.1128/MCB.14.1.463 · DOI
- Pearson, 2001, Mitogen-activated protein (MAP) kinase pathways: regulation and physiological functions, Endocr. Rev., 22, 153, 10.1210/er.22.2.153 · DOI · Paper page
- Radtke, 2013, ERK2 but not ERK1 mediates HGF-induced motility in non-small cell lung carcinoma cell lines, J. Cell Sci., 126, 2381, 10.1242/jcs.115832 · DOI
- Remy, 2010, Differential activation of p38MAPK isoforms by MKK6 and MKK3, Cell. Signal., 22, 660, 10.1016/j.cellsig.2009.11.020 · DOI
- Ring, 2011, Distinct patterns of activation-dependent changes in conformational mobility between ERK1 and ERK2, Int. J. Mass Spectrom., 302, 101, 10.1016/j.ijms.2010.08.020 · DOI · Paper page
- Risco, 2012, New Insights into the p38gamma and p38delta MAPK Pathways, J. Signal Transduct., 2012, 520289, 10.1155/2012/520289 · DOI · Paper page
- Risco, 2012, p38gamma and p38delta kinases regulate the Toll-like receptor 4 (TLR4)-induced cytokine production by controlling ERK1/2 protein kinase pathway activation, Proc. Natl. Acad. Sci. U.S.A., 109, 11200, 10.1073/pnas.1207290109 · DOI · Paper page
- Robbins, 1993, Regulation and properties of extracellular signal-regulated protein kinases 1 and 2 in vitro, J. Biol. Chem., 268, 5097, 10.1016/S0021-9258(18)53507-9 · DOI · Paper page
- Ronai, 2004, JNKing revealed, Mol. Cell, 15, 843, 10.1016/j.molcel.2004.09.011 · DOI
- Sabapathy, 2004, Distinct roles for JNK1 and JNK2 in regulating JNK activity and c-Jun-dependent cell proliferation, Mol. Cell, 15, 713, 10.1016/j.molcel.2004.08.028 · DOI · Paper page
- Sabapathy, 2004, JNK2: a negative regulator of cellular proliferation, Cell Cycle, 3, 1520, 10.4161/cc.3.12.1315 · DOI · Paper page
- Sabio, 2005, p38gamma regulates the localisation of SAP97 in the cytoskeleton by modulating its interaction with GKAP, EMBO J., 24, 1134, 10.1038/sj.emboj.7600578 · DOI · Paper page
- Sabio, 2010, p38gamma regulates interaction of nuclear PSF and RNA with the tumour-suppressor hDlg in response to osmotic shock, J. Cell Sci., 123, 2596, 10.1242/jcs.066514 · DOI
- Samuels, 2008, Deletion of ERK2 mitogen-activated protein kinase identifies its key roles in cortical neurogenesis and cognitive function, J. Neurosci., 28, 6983, 10.1523/JNEUROSCI.0679-08.2008 · DOI · Paper page
- Sarbassov, 1997, Extracellular signal-regulated kinase-1 and -2 respond differently to mitogenic and differentiative signaling pathways in myoblasts, Mol. Endocrinol., 11, 2038, 10.1210/mend.11.13.0036 · doi:10.1210/mend.11.13.0036 · Paper page
- Satoh, 2007, Extracellular signal-regulated kinase 2 (ERK2) knockdown mice show deficits in long-term memory; ERK2 has a specific function in learning and memory, J. Neurosci., 27, 10765, 10.1523/JNEUROSCI.0117-07.2007 · DOI · Paper page
- Saulnier, 2012, ERK1 regulates the hematopoietic stem cell niches, PLoS ONE, 7, e30788, 10.1371/journal.pone.0030788 · DOI
- Schaeffer, 1998, MP1: a MEK binding partner that enhances enzymatic activation of the MAP kinase cascade, Science, 281, 1668, 10.1126/science.281.5383.1668 · DOI · Paper page
- Selcher, 2001, Mice lacking the ERK1 isoform of MAP kinase are unimpaired in emotional learning, Learn. Mem., 8, 11, 10.1101/lm.37001 · DOI · Paper page
- Shaul, 2006, ERK1c regulates Golgi fragmentation during mitosis, J. Cell Biol., 172, 885, 10.1083/jcb.200509063 · DOI · Paper page
- Shin, 2013, Depletion of ERK2 but not ERK1 abrogates oncogenic Ras-induced senescence, Cell. Signal., 25, 2540, 10.1016/j.cellsig.2013.08.014 · DOI
- Shin, 2010, ERK2 but not ERK1 induces epithelial-to-mesenchymal transformation via DEF motif-dependent signaling events, Mol. Cell, 38, 114, 10.1016/j.molcel.2010.02.020 · DOI · Paper page
- Staser, 2013, Normal hematopoiesis and neurofibromin-deficient myeloproliferative disease require Erk, J. Clin. Invest., 123, 329, 10.1172/JCI66167 · DOI
- Tamura, 2000, Requirement for p38alpha in erythropoietin expression: a role for stress kinases in erythropoiesis, Cell, 102, 221, 10.1016/S0092-8674(00)00027-1 · DOI · Paper page
- Teis, 2006, p14-MP1-MEK1 signaling regulates endosomal traffic and cellular proliferation during tissue homeostasis, J. Cell Biol., 175, 861, 10.1083/jcb.200607025 · DOI · Paper page
- Teis, 2002, Localization of the MP1-MAPK scaffold complex to endosomes is mediated by p14 and required for signal transduction, Dev. Cell, 3, 803, 10.1016/S1534-5807(02)00364-7 · DOI · Paper page
- Trempolec, 2013, SnapShot: p38 MAPK signaling, Cell, 152, 656, 10.1016/j.cell.2013.01.029 · DOI
- Vantaggiato, 2006, ERK1 and ERK2 mitogen-activated protein kinases affect Ras-dependent cell signaling differentially, J. Biol., 5, 14, 10.1186/jbiol38 · DOI · Paper page
- Voisin, 2010, Genetic demonstration of a redundant role of extracellular signal-regulated kinase 1 (ERK1) and ERK2 mitogen-activated protein kinases in promoting fibroblast proliferation, Mol. Cell. Biol., 30, 2918, 10.1128/MCB.00131-10 · DOI · Paper page
- von Kriegsheim, 2009, Cell fate decisions are specified by the dynamic ERK interactome, Nat. Cell Biol., 11, 1458, 10.1038/ncb1994 · DOI · Paper page
- Warr, 2012, Gadd45gamma and Map3k4 interactions regulate mouse testis determination via p38 MAPK-mediated control of Sry expression, Dev. Cell, 23, 1020, 10.1016/j.devcel.2012.09.016 · DOI · Paper page
- Wei, 2010, Both ERK1 and ERK2 kinases promote G2/M arrest in etoposide-treated MCF7 cells by facilitating ATM activation, Cell. Signal., 22, 1783, 10.1016/j.cellsig.2010.07.007 · DOI
- Wille, 2007, Epi-allelic Erk1 and Erk2 knockdown series for quantitative analysis of T cell Erk regulation and IL-2 production, Mol. Immunol., 44, 3085, 10.1016/j.molimm.2007.02.008 · DOI
- Wollmann, 2005, The macrophage inhibitory cytokine integrates AKT/PKB and MAP kinase signaling pathways in breast cancer cells, Carcinogenesis, 26, 900, 10.1093/carcin/bgi031 · DOI
- Wunderlich, 2001, A novel 14-kilodalton protein interacts with the mitogen-activated protein kinase scaffold mp1 on a late endosomal/lysosomal compartment, J. Cell Biol., 152, 765, 10.1083/jcb.152.4.765 · DOI · Paper page
- Yoon, 2006, The extracellular signal-regulated kinase: multiple substrates regulate diverse cellular functions, Growth Factors, 24, 21, 10.1080/02699050500284218 · DOI · Paper page
- Yung, 2000, ERK1b, a 46-kDa ERK isoform that is differentially regulated by MEK, J. Biol. Chem., 275, 15799, 10.1074/jbc.M910060199 · DOI · Paper page
- Zur, 2015, Combined deletion of p38gamma and p38delta reduces skin inflammation and protects from carcinogenesis, Oncotarget, 6, 12920, 10.18632/oncotarget.4320 · DOI
Cited by
ERK signalling: A master regulator of cell behaviour, life and fate
Lavoie, H., Gagnon, J., & Therrien, M. (2020) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-020-0255-7 · Cited by 1,185
JNK-signaling: A multiplexing hub in programmed cell death
Dhanasekaran, D. N., & Reddy, E. P. (2017) · Genes & Cancer · doi:10.18632/genesandcancer.155 · Cited by 358
Determining the ERK-regulated phosphoproteome driving KRAS-mutant cancer
Klomp, J. E., Diehl, J. N., Klomp, J. A., Edwards, A. C., Yang, R., Morales, A. J., Taylor, K. E., Drizyte-Miller, K., Bryant, K. L., Schaefer, A., et al. (2024) · Science · doi:10.1126/science.adk0850 · Cited by 83
Cingolani, F., Liu, Y., Shen, Y., Wen, J., Farris, A. B., & Czaja, M. J. (2022) · Hepatology Communications · doi:10.1002/hep4.1867 · Cited by 18
Metadata
- Authors
- Saba-El-Leil, M. K., Frémin, C., & Meloche, S.
- Venue
- Frontiers in Cell and Developmental Biology
- Publisher
- Frontiers Media SA
- Published
- 2016-06-27
- Volume
- 4
- Pages
- 67-67
- ISSN
- 2296-634X (ISSN-L)
- OpenAlex
- W2466439203
- Cited by
- 60
- References
- 13
- FWCI
- 3.91
- Type
- journal article
- Language
- en
- Open access
- gold
- Funders
- Canadian Institutes of Health Research (MOP-119327)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Redundancy in the World of MAP Kinases: All for One. https://app.cochat.ai/papers/10.3389/fcell.2016.00067
- The paper
- Saba-El-Leil, M. K., Frémin, C., & Meloche, S. (2016). Redundancy in the World of MAP Kinases: All for One. Frontiers in Cell and Developmental Biology. https://doi.org/10.3389/fcell.2016.00067
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.